ResMed (RMD)
(Delayed Data from NYSE)
$197.04 USD
-11.30 (-5.42%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $197.20 +0.16 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Brokerage Reports
0 items in cart
ResMed Inc. [RMD]
Reports for Purchase
Showing records 421 - 440 ( 531 total )
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Discontinuation of Research Coverage
Provider: Feltl & Company
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q2 FY2017 ahead of consensus and nice rebound from Q1, maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Q4 CY2016 Feltl CPAP Project 2005-2016: 19,000+ patient historical analysis
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q1 FY2017 missed consensus, Americas mask share slips, maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Q3 CY2016 CPAP Project 2005-2016: 19,000+ patient historical analysis
Provider: Feltl & Company
Analyst: HAYNOR B